Recombinant MED12 抗体 (AA 2127-2177)
Our Local Distributor
北京 101111
Quick Overview for Recombinant MED12 抗体 (AA 2127-2177) (ABIN7453977)
抗原
See all MED12 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 2127-2177
-
原理
- Rabbit anti-MED12 Recombinant Monoclonal Antibody [BLR084G] - BSA-Free
-
纯化方法
- Purified
-
免疫原
- between AA 2127 and 2177 (C-term)
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1000 μg/mL
-
缓冲液
- Borate Buffered Saline (BBS) pH 8.2 with 0.09 % Sodium Azide, BSA-Free
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
储存方法
- 2 - 8 °C
-
有效期
- 12 months
-
-
- MED12 (Mediator Complex Subunit 12 (MED12))
-
别名
- MED12
-
背景
- MED12 is a component of the multisubunit mediator complex that functions as an interface between gene-specific transcription factors and the RNA Pol II/general transcription factor machinery. The mediator complex was first identified as a coactivator of the thyroid hormone receptor and has since been observed to function as a coactivator of a variety of transcription factors. In this context, MED12 interaction with beta-catenin has been shown to be required for Wnt-signaling dependent transcription.
-
基因ID
- 9968
-
UniProt
- Q93074
-
途径
- Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Stem Cell Maintenance, Chromatin Binding, Regulation of Lipid Metabolism by PPARalpha, Tube Formation
抗原
-